company science partnership investor media careers contact

News home fact sheet investor news publications contact

News Welcome to the Proximagen Newsroom. In this section you will find information not only about Proximagen, but about the latest in neurodegenerative research. Check back often for updates. DATE: TITLE: MORE: SOURCE: 01/02/10 Proximagen on acquisition trail with 55.5m war chest full story IB Times 15/01/10 The welcome shrinkage of junior market's long tail full story Financial Times 04/01/10 Proximagen buys Minster for £4.3m full story Financial Times 02/02/09 New non-executive chairman for Proximagen full story The Independent 28/07/08 Boost for biotechs by Proxi full story The Independent 24/07/08 Proximagen seals a deal full story Shares Magazine 24/07/08 Proximagen Signs Licensing Agreement with Upsher-Smith full story BioCentury 16/07/08 Proximagen Signs Licensing Agreement with Upsher-Smith full story BioWorld International (AHC Media) 02/01/08 Share tips 2008 full story The Independent 23/06/07 Extras, extras! full story New Scientist 21/06/07 The Investment Column full story The Independent 14/06/07 Proximagen Shares Magazine Article full story Shares Magazine 07/03/07 Proximagen reveals promising alternative to L-DOPA for Parkinson's disease full story Scrip World Pharmaceutical News 23/11/06 Mini-Symposium and Pipeline Update full story Company release 24/07/06 Significant Contract Win full story Company release 22/05/06 In-Licencing Agreement full story Company release 24/11/05 Business initiative of the year award full story Company release 27/7/05 Proximagen interim results full story Financial Times 29/3/05 CNBC Power Lunch Interview (large file) media file CNBC 29/3/05 University floats spinout full story Daily Express 15/3/05 Proximagen to list on AiM full story Financial Times 3/12/04 Entrepreneurs Welcome Science Spotlight full story The Guardian 15/8/04 Neuroscience Research Company Launched full story The Messenger 18/3/04 Stock Market News: Proximagen is a spinout from Kings full story Market Release